Nanotherapies for the Treatment of Age-Related Macular Degeneration (AMD) Disease: Recent Advancements and Challenges
Author:
Affiliation:
1. Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India
2. Formulation development, Slayback Pharma India LLP, Hyderabad 500072, Telangana, India
Abstract
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmaceutical Science,Biomedical Engineering,General Medicine
Reference50 articles.
1. Mitchell P.; Liew G.; Gopinath B.; Wong T.Y.; Age-related macular degeneration. Lancet (London, England) 2018,392(10153),1147-1159
2. Sarwar S; Clearfield E; Soliman MK; Aflibercept for neovascular age-related macular degeneration Cochrane Database Syst Rev 2016 2CD011346
3. Falavarjani K.G.; Nguyen Q.D.; Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond) 2013,27(7),787-794
4. Müller S.; Ehlken C.; Bauer-Steinhusen U.; Lechtenfeld W.; Hasanbasic Z.; Agostini H.; Wilke T.; Treatment of age-related neovascular macular degeneration: the patient’s perspective. Graefes Arch Clin Exp Ophthalmol 2017,255(11),2237-2246
5. Klein R.; Peto T.; Bird A.; Vannewkirk M.R.; The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004,137(3),486-495
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Age-Related Macular Degeneration - Therapies and Their Delivery;Current Drug Delivery;2024-06
2. A concentrated machine learning-based classification system for age-related macular degeneration (AMD) diagnosis using fundus images;Scientific Reports;2024-01-29
3. Nanocarriers for ocular drug delivery: Recent advances and future opportunities;Indian Journal of Ophthalmology;2023-06
4. Inception V3 Based Approach for the Recognition of Age-related macular degeneration Disease;2023 International Conference on Science, Engineering and Business for Sustainable Development Goals (SEB-SDG);2023-04-05
5. Complex ophthalmic formulation technologies: Advancement and future perspectives;Journal of Drug Delivery Science and Technology;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3